Amedeo Smart

Free Medical Literature Service

 

Amedeo

Valvular Heart Disease
  Free Subscription

Articles published in
Eur Heart J
    October 2025
  1. GORI T, Treede H
    Equal tools, unequal tolls: should sex influence decision-making for aortic valve stenosis?
    Eur Heart J. 2025 Oct 9:ehaf762. doi: 10.1093.
    >> Share

    September 2025
  2. ARMOUNDAS AA
    The electrocardiogram reimagined: AI-ECG as a prognostic beacon for valvular heart disease.
    Eur Heart J. 2025 Sep 5:ehaf584. doi: 10.1093.
    >> Share

  3. CUDDY SAM
    Aortic stenosis: need for treatment of co-existent cardiac amyloidosis?
    Eur Heart J. 2025 Sep 5:ehaf558. doi: 10.1093.
    >> Share

  4. BLEIZIFFER S, Leuschner F, Rudolph TK, Vonthein R, et al
    Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial.
    Eur Heart J. 2025 Sep 3:ehaf519. doi: 10.1093.
    >> Share

  5. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    >> Share

    August 2025
  6. LURZ P, Hahn RT, Kodali S, Makkar R, et al
    Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
    Eur Heart J. 2025 Aug 29:ehaf676. doi: 10.1093.
    >> Share

  7. PRAZ F, Borger MA, Lanz J, Marin-Cuartas M, et al
    2025 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2025 Aug 29:ehaf194. doi: 10.1093.
    >> Share

  8. MAURIZI N, Monda E, Biagini E, Field E, et al
    Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.
    Eur Heart J. 2025;46:3082-3094.
    >> Share

  9. BUTERA G, Montanaro C, Maisano F
    Multiple clips for transcatheter mitral valve repair in failing Fontan.
    Eur Heart J. 2025 Aug 12:ehaf469. doi: 10.1093.
    >> Share

  10. ADAMO M, Pagnesi M, Ajmone Marsan N, Bauersachs J, et al
    Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach.
    Eur Heart J. 2025 Aug 1:ehaf480. doi: 10.1093.
    >> Share

    July 2025
  11. WATANABE A, Hiruma Y, Asanuma T
    Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf539. doi: 10.1093.
    >> Share

  12. NITSCHE C, Ristl R, Treibel TA
    Avoiding immortal time bias for cardiac transthyretin treatment in aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf542. doi: 10.1093.
    >> Share

  13. LI Y, Wei L, Zhang C
    Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients.
    Eur Heart J. 2025 Jul 25:ehaf536. doi: 10.1093.
    >> Share

  14. CREA F
    Challenges in antithrombotic treatment and in the management of valvular heart disease.
    Eur Heart J. 2025;46:2717-2721.
    >> Share

  15. LIANG Y, Sau A, Zeidaabadi B, Barker J, et al
    Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study.
    Eur Heart J. 2025 Jul 16:ehaf448. doi: 10.1093.
    >> Share

  16. ALHAKAK A, Butt JH, Havers-Borgersen E, Ostergaard L, et al
    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
    Eur Heart J. 2025 Jul 11:ehaf342. doi: 10.1093.
    >> Share

  17. GIACOPPO D
    Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.
    Eur Heart J. 2025 Jul 11:ehaf099. doi: 10.1093.
    >> Share

  18. KANEKO T, Kagiyama N, Okazaki S, Amano M, et al
    Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2025 Jul 9:ehaf511. doi: 10.1093.
    >> Share

  19. LIU H, Fang Y, Cheng W
    Traumatic interventricular septal dissection in a bicuspid aortic valve patient: a rare extension into the left ventricle.
    Eur Heart J. 2025 Jul 4:ehaf499. doi: 10.1093.
    >> Share

  20. BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al
    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.
    Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093.
    >> Share

    June 2025
  21. KARTHIKEYAN G, Rajashekar P, Devasenapathy N, Biswas S, et al
    Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial.
    Eur Heart J. 2025 Jun 27:ehaf391. doi: 10.1093.
    >> Share

  22. YANG WL, Hu BY
    Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation associated with familial thoracic aortic aneurysm type 10.
    Eur Heart J. 2025 Jun 24:ehaf402. doi: 10.1093.
    >> Share

  23. CREA F
    Focus on juvenile hypertension, deep learning-qualified body composition for risk stratification, infective endocarditis, and mixed valvular heart disease.
    Eur Heart J. 2025;46:2249-2252.
    >> Share

  24. COMPAGNONE M, Windecker S, Dall'Ara G, Galvani M, et al
    Great debate: Transcatheter aortic valve implantation should also be performed in non-surgical centres.
    Eur Heart J. 2025 Jun 5:ehaf363. doi: 10.1093.
    >> Share

  25. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
    Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
    >> Share

    May 2025
  26. BASU J, Nikoletou D, Miles C, MacLachlan H, et al
    High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.
    Eur Heart J. 2025;46:1803-1815.
    >> Share

  27. ISHIKAWA E, Kageyama S
    Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral regurgitation.
    Eur Heart J. 2025 May 13:ehaf334. doi: 10.1093.
    >> Share

  28. BARBANTI M, Costa G, Windecker S, Maisano F, et al
    Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation.
    Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093.
    >> Share

  29. PEDICINO D, Liuzzo G
    Weekly Journal Scan: does dapagliflozin expand the therapeutic options after transcatheter aortic valve implantation?
    Eur Heart J. 2025 May 6:ehaf309. doi: 10.1093.
    >> Share

  30. LIN S, Zhang H, Li Z
    Quadricuspid aortic valve with partial left coronary sinus isolation.
    Eur Heart J. 2025 May 2:ehaf252. doi: 10.1093.
    >> Share

    April 2025
  31. VAN KAMPEN A, Levine RA, Borger MA
    Is mitral annular disjunction the cause of arrhythmogenic mitral valve prolapse?
    Eur Heart J. 2025 Apr 24:ehaf264. doi: 10.1093.
    >> Share

  32. COISNE A, Lancellotti P, Cote N, Ternacle J, et al
    Blood biomarkers in left-sided valvular heart disease.
    Eur Heart J. 2025 Apr 22:ehaf232. doi: 10.1093.
    >> Share

  33. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    >> Share

  34. ZITO F, Rhellab R, de Keijzer AR
    Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
    Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
    >> Share

  35. PATEL KP, Baumbach A
    Clinical implications of sex-related differences in severe aortic stenosis.
    Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093.
    >> Share

  36. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
    Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
    Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
    >> Share

    March 2025
  37. LONG A, Finer J, Hartman H, Hartzel D, et al
    Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
    Eur Heart J. 2025 Mar 29:ehaf248. doi: 10.1093.
    >> Share

  38. CHEN M, Michel J, Kasel AM
    26 mm SAPIEN fractured 23 mm SAPIEN and surgical prosthesis: a transcatheter aortic valve-in-valve-in-valve implantation.
    Eur Heart J. 2025 Mar 29:ehaf173. doi: 10.1093.
    >> Share

  39. INDOLFI C, Esposito G, Luscher TF
    TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation.
    Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093.
    >> Share

    February 2025
  40. MOCUMBI A
    European Society of Cardiology guidelines for the management of valvular heart disease: should we apply these to rheumatic heart disease?
    Eur Heart J. 2025 Feb 28:ehae641. doi: 10.1093.
    >> Share

  41. UNGER P, Galloo X, Pibarot P
    Mixed valvular heart disease: diagnosis and management.
    Eur Heart J. 2025 Feb 27:ehaf116. doi: 10.1093.
    >> Share

  42. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    The Year in Cardiovascular Medicine 2024: the top 10 papers in valvular heart disease.
    Eur Heart J. 2025 Feb 27:ehaf071. doi: 10.1093.
    >> Share

  43. PEDICINO D, Vergallo R
    Weekly Journal Scan: is transcatheter replacement therapy for tricuspid regurgitation ready for prime time?
    Eur Heart J. 2025 Feb 19:ehaf060. doi: 10.1093.
    >> Share

  44. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
    Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
    Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
    >> Share

  45. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
    Current status of aortic valve repair surgery.
    Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
    >> Share

  46. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe aortic valve stenosis and obstructive coronary artery disease.
    Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093.
    >> Share

  47. CREA F
    Focus on aortic stenosis prevention and mitral regurgitation diagnosis.
    Eur Heart J. 2025;46:595-597.
    >> Share

  48. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
    >> Share

  49. ANGELLOTTI D, Praz F, Windecker S
    Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay.
    Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093.
    >> Share

    January 2025
  50. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
    Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
    >> Share

  51. LURZ P, Zancanaro E, Kresoja KP
    Personalized management of tricuspid valve regurgitation.
    Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093.
    >> Share

  52. AARTS HM, Voskuil M, Delewi R
    Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
    Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
    >> Share

    December 2024
  53. ANG DTY, Lindsay MM
    Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093.
    >> Share

  54. GARCIA-PAVIA P, Oreziak A, Masri A, Barriales-Villa R, et al
    Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2024;45:5071-5083.
    >> Share

  55. VERGALLO R, Pedicino D
    Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve implantation in asymptomatic patients with severe aortic stenosis.
    Eur Heart J. 2024 Dec 11:ehae839. doi: 10.1093.
    >> Share

  56. SUN Y, Wang Z, Qian Y
    What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
    Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
    >> Share

  57. NASER JA, Siontis KC, Nkomo VT
    The steps towards understanding tricuspid regurgitation: one 'careful' step at a time and many more 'careful' steps needed.
    Eur Heart J. 2024 Dec 4:ehae816. doi: 10.1093.
    >> Share

  58. HALLE M, Wernhart S, Krane M
    Exercise in primary, secondary and tertiary prevention of aortic stenosis.
    Eur Heart J. 2024 Dec 4:ehae627. doi: 10.1093.
    >> Share

  59. BLASER MC, Back M, Luscher TF, Aikawa E, et al
    Calcific aortic stenosis: omics-based target discovery and therapy development.
    Eur Heart J. 2024 Dec 4:ehae829. doi: 10.1093.
    >> Share

    November 2024
  60. GARG P, Pavon AG, Penicka M, Uretsky S, et al
    Cardiovascular magnetic resonance imaging in mitral valve disease.
    Eur Heart J. 2024 Nov 20:ehae801. doi: 10.1093.
    >> Share

  61. LI Z, Xiang D, Hu K
    Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
    Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
    >> Share

  62. VERGALLO R, Pedicino D
    Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?
    Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093.
    >> Share

  63. COATS CJ, Masri A, Barriales-Villa R, Abraham TP, et al
    Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
    Eur Heart J. 2024;45:4464-4478.
    >> Share

  64. CREA F
    Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, and acute heart failure.
    Eur Heart J. 2024;45:4451-4455.
    >> Share

    October 2024
  65. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
    Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
    Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
    >> Share

  66. PEDICINO D, Vergallo R
    Weekly Journal Scan: RESHAPing potential treatment indications for functional mitral regurgitation in heart failure.
    Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093.
    >> Share

  67. PEDICINO D, Vergallo R
    Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral regurgitation? Still climbing.
    Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093.
    >> Share

  68. DE CATERINA R, Ten Cate H, Pengo V
    Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging.
    Eur Heart J. 2024 Oct 8:ehae615. doi: 10.1093.
    >> Share

  69. LANCELLOTTI P, Go YY, Vannan MA
    Unveiling sex differences in valvular disease care and outcomes.
    Eur Heart J. 2024;45:3834-3836.
    >> Share

    September 2024
  70. TALHA KM, Metra M, Butler J
    Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation.
    Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093.
    >> Share

  71. SCHOFER N, Blankenberg S
    Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
    Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
    >> Share

  72. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    >> Share

  73. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    >> Share

  74. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    >> Share

  75. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    >> Share

  76. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    >> Share

    August 2024
  77. BONAROS N, Gollmann-Tepekoylu C, Grimm M
    Tricuspid valve trilogy: between risks and timing for surgery.
    Eur Heart J. 2024 Aug 30:ehae562. doi: 10.1093.
    >> Share

  78. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    >> Share

  79. MASCHERBAUER J, Kammerlander A, Nitsche C, Bax J, et al
    Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
    Eur Heart J. 2024 Aug 30:ehae523. doi: 10.1093.
    >> Share

  80. NOTENBOOM ML, de Keijzer AR, Veen KM, Gokalp A, et al
    Sex-related differences in the clinical course of aortic root and ascending aortic aneurysms: the DisSEXion Study.
    Eur Heart J. 2024 Aug 26:ehae525. doi: 10.1093.
    >> Share

  81. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    >> Share

  82. MACH F, Miteva K
    Window of opportunity for developing effective medical intervention for calcific aortic valve disease.
    Eur Heart J. 2024 Aug 12:ehae426. doi: 10.1093.
    >> Share

  83. LOPES LR, Ho CY, Elliott PM
    Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.
    Eur Heart J. 2024;45:2727-2734.
    >> Share

    July 2024
  84. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    >> Share

  85. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    >> Share

  86. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    >> Share

  87. CREA F
    A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
    Eur Heart J. 2024;45:2267-2270.
    >> Share

  88. ARSENOS P, Tsioufis K, Gatzoulis KA
    Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients.
    Eur Heart J. 2024;45:2341-2342.
    >> Share

  89. HUANG Y, Wang C, Zhou T, Xie F, et al
    Lumican promotes calcific aortic valve disease through H3 histone lactylation.
    Eur Heart J. 2024 Jul 8:ehae407. doi: 10.1093.
    >> Share

  90. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    >> Share

  91. JAHANYAR J, de Kerchove L, El Khoury G
    Forme fruste unicuspid aortic valves.
    Eur Heart J. 2024 Jul 3:ehae432. doi: 10.1093.
    >> Share

  92. THYREGOD HGH, De Backer O, Sondergaard L
    A notion of bioprosthetic aortic valve durability.
    Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
    >> Share

  93. LI Z, Cheng S, Guo B, Ding L, et al
    Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.
    Eur Heart J. 2024 Jul 2:ehae406. doi: 10.1093.
    >> Share

  94. BEKKI M, Tahara N, Fukumoto Y
    Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
    Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
    >> Share

  95. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
    Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
    >> Share

  96. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
    Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
    Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
    >> Share

    June 2024
  97. HAHN RT
    Sex-related differences in degenerative mitral regurgitation: a call to action.
    Eur Heart J. 2024 Jun 13:ehae360. doi: 10.1093.
    >> Share

  98. ZHUANG Y, Wang W, Lu F
    Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
    Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
    >> Share

  99. CREA F
    Optimizing the treatment of severe aortic stenosis.
    Eur Heart J. 2024;45:1861-1865.
    >> Share

  100. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
    Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
    >> Share

    May 2024
  101. ELTCHANINOFF H, Durand E
    Transfemoral aortic valve implantation and concomitant CAD: the jury is out.
    Eur Heart J. 2024 May 31:ehae141. doi: 10.1093.
    >> Share

  102. WANG J, Chen X, Zhao S
    Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
    Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
    >> Share


  103. Correction to: Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 May 27:ehae144. doi: 10.1093.
    >> Share

  104. AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al
    Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes.
    Eur Heart J. 2024 May 16:ehae265. doi: 10.1093.
    >> Share

  105. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    >> Share

  106. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
    Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
    Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
    >> Share

  107. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
    Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
    >> Share

  108. ZEPPENFELD K, de Riva M
    Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
    Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
    >> Share

    April 2024
  109. PIBAROT P
    Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
    Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
    >> Share

  110. PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al
    Anderson-Fabry disease management: role of the cardiologist.
    Eur Heart J. 2024;45:1395-1409.
    >> Share

  111. KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al
    Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
    Eur Heart J. 2024;45:1443-1454.
    >> Share

  112. TAHARA N, Fukumoto Y, Tayama E
    Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2024;45:1488.
    >> Share

  113. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    >> Share

    March 2024
  114. FRANK D, Durand E, Lauck S, Muir DF, et al
    A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
    Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
    >> Share


  115. Correction to: Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093.
    >> Share

  116. BAKAR SN, Ong G, Fam NP
    LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
    Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
    >> Share


  117. Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
    Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
    >> Share

  118. CREA F
    Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
    Eur Heart J. 2024;45:857-860.
    >> Share

  119. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    >> Share

  120. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    >> Share

  121. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    >> Share

  122. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    >> Share

  123. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    >> Share

  124. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    >> Share

  125. MCGREGOR M, Bews H, Jassal DS
    Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
    Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
    >> Share

  126. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    >> Share

    February 2024
  127. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    >> Share

  128. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    >> Share

  129. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    >> Share

  130. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    >> Share

  131. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    >> Share

  132. CREA F
    The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
    Eur Heart J. 2024;45:317-320.
    >> Share

    January 2024
  133. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
    Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
    Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
    >> Share

  134. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  135. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  136. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    >> Share

  137. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    >> Share

  138. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    >> Share

  139. LONG X, Deng S, Liu W, Bu J, et al
    Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
    Eur Heart J. 2024;45:233-235.
    >> Share

  140. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    >> Share

  141. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    >> Share

  142. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    >> Share

    December 2023
  143. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
    Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:5146-5158.
    >> Share

  144. INGLES J, MacArthur DG
    The moral and practical urgency of increasing diversity in genomics.
    Eur Heart J. 2023;44:5157-5159.
    >> Share

  145. ANDREAS M, Burri H, Praz F, Soliman O, et al
    Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
    >> Share

  146. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    >> Share

  147. GRANI C
    Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4793-4795.
    >> Share

  148. WANG J, Yang S, Ma X, Zhao K, et al
    Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
    Eur Heart J. 2023;44:4781-4792.
    >> Share

    November 2023
  149. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    >> Share

  150. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    >> Share

  151. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4622-4633.
    >> Share

  152. TOMII D, Praz F, Windecker S
    Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
    Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
    >> Share

  153. CREA F
    Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
    Eur Heart J. 2023;44:4493-4496.
    >> Share

  154. PATEL KP, Baumbach A
    Timing treatment for tricuspid regurgitation.
    Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
    >> Share

  155. WERT L, Falk V, Potapov EV
    Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
    Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
    >> Share

  156. IDHREES M, Kumar A, Velayudhan B
    'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
    Eur Heart J. 2023;44:4392.
    >> Share

  157. KODALI S, Hahn RT, Makkar R, Makar M, et al
    Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
    Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
    >> Share

    October 2023
  158. HARARI E, Landes U
    Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
    Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
    >> Share

  159. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
    Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
    Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
    >> Share

  160. DE BACKER J, Prakash SK
    Refining the course: long-term outcome in patients with bicuspid aortic valve.
    Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
    >> Share

  161. FARJAT-PASOS JI, Dumont E, Paradis JM
    Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
    Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
    >> Share

  162. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
    >> Share

  163. WEISSLER-SNIR A, Rakowski H, Meyer M
    Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
    Eur Heart J. 2023;44:3655-3657.
    >> Share

  164. DEVRIES JH, Irs A, Hillege HL
    The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
    Eur Heart J. 2023;44:3492-3494.
    >> Share

    September 2023
  165. CHHABRA ST, Takkar A, Arya RC
    An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
    Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
    >> Share

  166. BEYGUI F, Guillemot V, Saloux E
    Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
    Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
    >> Share

  167. MOORE JP, Aboulhosn JA, Khairy P
    Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
    Eur Heart J. 2023;44:3228-3230.
    >> Share

  168. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    >> Share

  169. FENG S, Wu F, Pan X
    Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
    Eur Heart J. 2023;44:3199.
    >> Share

    August 2023
  170. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
    Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
    Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
    >> Share

  171. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
    TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
    Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
    >> Share

  172. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
    Bicuspid aortic valve: long-term morbidity and mortality.
    Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
    >> Share

  173. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
    Severe aortic stenosis detection by deep learning applied to echocardiography.
    Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
    >> Share

  174. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
    End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
    Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
    >> Share

  175. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    >> Share

  176. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    >> Share

  177. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    >> Share

  178. EIROS R, Gallego-Delgado M, Villacorta E
    Unravelling an hypertrophic myocardiopathy.
    Eur Heart J. 2023;44:2788.
    >> Share

    July 2023
  179. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
    Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
    Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
    >> Share

  180. WALDSCHMIDT L, Seiffert M
    Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
    Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
    >> Share

  181. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
    Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
    Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
    >> Share

  182. LORENZATTI D, Pina P, Slipczuk L
    Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
    Eur Heart J. 2023;44:2350.
    >> Share

    June 2023
  183. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
    Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
    Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
    >> Share

  184. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    >> Share


  185. Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
    >> Share

  186. TAKANO R, Tsuji A, Ogo T
    A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
    Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
    >> Share

  187. PEDICINO D, Vergallo R
    Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
    Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
    >> Share

  188. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
    Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
    Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
    >> Share

  189. EVANGELISTA A, Michelena HI
    Family screening for bicuspid aortic valve: indicated, but easy to implement?
    Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
    >> Share

  190. CREA F
    Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
    Eur Heart J. 2023;44:1847-1850.
    >> Share

    May 2023
  191. LORENZINI M, Elliott PM
    Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
    Eur Heart J. 2023;44:1519-1521.
    >> Share

  192. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    >> Share

    April 2023
  193. BUTCHER SC, Essayagh B, Enriquez-Sarano M
    Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
    Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
    >> Share

  194. DANDEL M
    Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
    Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
    >> Share

  195. LI Y, He Q, Xie M
    A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
    Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
    >> Share

  196. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share

  197. PEDICINO D, Vergallo R
    Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
    Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
    >> Share

  198. ORRINGER CE
    C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
    Eur Heart J. 2023;44:1461-1463.
    >> Share

  199. THERIAULT S, Mathieu P, Bosse Y
    The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
    Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
    >> Share

  200. CHEN HY, Dina C, Small AM, Shaffer CM, et al
    Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
    Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
    >> Share

  201. SEQUEIRA V, Batzner A, Maack C
    Targeting mitochondria in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:1186-1188.
    >> Share

  202. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
    Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
    Eur Heart J. 2023;44:1170-1185.
    >> Share

    March 2023
  203. KAGASE A, Yamamoto M, Tokuda T
    Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
    Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
    >> Share

  204. XIE Z, Zhu H
    A rare case of mitral regurgitation caused by primary aldosteronism.
    Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
    >> Share

  205. CHEN YH, Chang HH, Leu HB
    Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
    Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
    >> Share

  206. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
    Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
    Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
    >> Share

  207. CHORIN E, Topilsky Y
    The synergy between tricuspid regurgitation and machine learning.
    Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
    >> Share

  208. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
    Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
    Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
    >> Share

  209. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
    Unmet needs in valvular heart disease.
    Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
    >> Share

  210. CHUNG CJ, Otto CM
    Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
    Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
    >> Share

  211. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
    Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
    Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
    >> Share

  212. CREA F
    Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
    Eur Heart J. 2023;44:783-787.
    >> Share

  213. RODES-CABAU J, Nuche J
    Are contemporary TAVI results influenced by hospital volume?
    Eur Heart J. 2023;44:868-870.
    >> Share

  214. CHEN J, Yang Y, Wei L
    One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
    Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
    >> Share

  215. KEMALOGLU OZ T, Badano LP
    Can three-dimensional echocardiography change the game for the pulmonary valve?
    Eur Heart J. 2023;44:703-705.
    >> Share

    October 2021
  216. ELLIOTT P
    Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
    Eur Heart J. 2021;42:3945-3947.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016